Company Filing History:
Years Active: 2018
Title: Yasuo Kodama: Innovator in Heat Shock Protein Research
Introduction
Yasuo Kodama is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical research, particularly in the area of heat shock proteins. His work focuses on developing therapeutic agents for patients resistant to known HSP90 inhibitors.
Latest Patents
Kodama holds a patent for a resistant mutant 90 kDa heat shock protein. The objective of this invention is to identify patients who are resistant to known HSP90 inhibitors. The patent provides a novel therapeutic agent aimed at treating these patients. The invention identifies patients based on a specific protein, which is an HSP90 family protein with a mutation corresponding to F138 of HSP90α class A. The active ingredient of the therapeutic agent is a substance that inhibits this protein.
Career Highlights
Yasuo Kodama is associated with Taiho Pharmaceutical Company Limited, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of heat shock proteins and their implications in therapeutic contexts.
Collaborations
Kodama has collaborated with notable colleagues, including Chihoko Yoshimura and Shuichi Ohkubo. These collaborations have further enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Yasuo Kodama's contributions to the field of heat shock protein research highlight his role as an innovator. His patent for a resistant mutant 90 kDa heat shock protein represents a significant advancement in therapeutic strategies for resistant patients. His work continues to inspire advancements in medical research and treatment options.